New York, October 28, 2015 – Cellectis (Alternext: ALCLS – Nasdaq: CLLS) today announced that a series of three production runs of UCART19, its lead TALEN® gene edited product candidate, was performed ...
Our Cell Processing Facility (CPF) is a Good Manufacturing Practice, or GMP, bioprocessing manufacturing facility that supports the reproducible production of human hematopoietic or immune-competent ...
BEVERLY HILLS, California, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (NORD) (“Nordicus” or the “Company”), a financial consulting ...
TUSTIN, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to ...
WEST SACRAMENTO, Calif., March 28, 2023 /PRNewswire/ -- Gemini Bioproducts, LLC ("GeminiBio"), a leading manufacturer of cell culture products and custom cGMP bioprocess liquids for the biotech ...
This executive summary explores the rapid growth of the cell therapy market and addresses the key challenges faced by sponsors in advancing clinical trials and commercializing therapies. It highlights ...
Colombian and Mexican GMP certifications expected during Q1'21 and Q2'21, respectively The Company confirms that its recently completed Processing and Extraction Center at its Rionegro facility, ...
PITTSBURGH, Nov. 7, 2019 /PRNewswire/ -- Thar Process, founded in 1990, announced today that after years of holding a Certified Organic certificate for algae extraction, it now holds the same for hemp ...
Thar Process becomes first Certified cGMP + Certified USDA Organic Hemp Toll Processor PITTSBURGH, Nov. 7, 2019 /PRNewswire/ -- Thar Process, founded in 1990, announced today that after years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results